Interferon Beta-1A + Placebo
Phase 2Terminated 0 views this week 0 watching💤 Quiet
Interest: 17/100
17
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Preventive Medicine
Conditions
Preventive Medicine, Multi Organ Failure
Trial Timeline
Feb 18, 2017 → Oct 3, 2019
NCT ID
NCT03119701About Interferon Beta-1A + Placebo
Interferon Beta-1A + Placebo is a phase 2 stage product being developed by Faron Pharmaceuticals for Preventive Medicine. The current trial status is terminated. This product is registered under clinical trial identifier NCT03119701. Target conditions include Preventive Medicine, Multi Organ Failure.
What happened to similar drugs?
0 of 1 similar drugs in Preventive Medicine were approved
Approved (0) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
12
Activity
0
Company
5
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03119701 | Phase 2 | Terminated |
| NCT02622724 | Phase 3 | Terminated |
Competing Products
1 competing product in Preventive Medicine
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Azithromycin plus chloroquine + sulfadoxine-pyrimethamine | Pfizer | Phase 3 | 32 |